Beyond aerobic glycolysis : Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis,Anthony A. Mancuso,Evgueni Daikhin,Ilana Nissim,Marc Yudkoff,Suzanne Wehrli,Craig B. Thompson +6 more
TLDR
Transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools, and glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.Abstract:
Tumor cell proliferation requires rapid synthesis of macromolecules including lipids, proteins, and nucleotides. Many tumor cells exhibit rapid glucose consumption, with most of the glucose-derived carbon being secreted as lactate despite abundant oxygen availability (the Warburg effect). Here, we used 13C NMR spectroscopy to examine the metabolism of glioblastoma cells exhibiting aerobic glycolysis. In these cells, the tricarboxylic acid (TCA) cycle was active but was characterized by an efflux of substrates for use in biosynthetic pathways, particularly fatty acid synthesis. The success of this synthetic activity depends on activation of pathways to generate reductive power (NADPH) and to restore oxaloacetate for continued TCA cycle function (anaplerosis). Surprisingly, both these needs were met by a high rate of glutamine metabolism. First, conversion of glutamine to lactate (glutaminolysis) was rapid enough to produce sufficient NADPH to support fatty acid synthesis. Second, despite substantial mitochondrial pyruvate metabolism, pyruvate carboxylation was suppressed, and anaplerotic oxaloacetate was derived from glutamine. Glutamine catabolism was accompanied by secretion of alanine and ammonia, such that most of the amino groups from glutamine were lost from the cell rather than incorporated into other molecules. These data demonstrate that transformed cells exhibit a high rate of glutamine consumption that cannot be explained by the nitrogen demand imposed by nucleotide synthesis or maintenance of nonessential amino acid pools. Rather, glutamine metabolism provides a carbon source that facilitates the cell's ability to use glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors.read more
Citations
More filters
Journal ArticleDOI
Toward precision medicine of breast cancer
TL;DR: It is shown how the interaction of high-throughput technologies with in silico modeling has led to set up useful inferences for promising strategies of target-specific therapies with low secondary effect incidence for patients.
Journal ArticleDOI
Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features
Qing Ouyang,Tojo Nakayama,Ozan Baytas,Shawn M. Davidson,Chendong Yang,Michael Schmidt,Sofia B. Lizarraga,Sasmita Mishra,Malak Ei-Quessny,Saima Niaz,Mirrat Gul Butt,Syed Imran Murtaza,Afzal Javed,Haroon Rashid Chaudhry,Dylan J. Vaughan,R. Sean Hill,Jennifer N. Partlow,Seung Yun Yoo,Anh Thu N. Lam,Ramzi Nasir,Muna Al-Saffar,A. James Barkovich,Matthew Schwede,Shailender Nagpal,Anna Rajab,Ralph J. DeBerardinis,David E. Housman,Ganeshwaran H. Mochida,Eric M. Morrow +28 more
TL;DR: An important role is revealed for the GPT2 enzyme in mitochondrial metabolism with relevance to developmental as well as potentially to neurodegenerative mechanisms in large kindreds initially ascertained for intellectual and developmental disability.
Journal ArticleDOI
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
Mala Shanmugam,Samuel K. McBrayer,Jun Qian,Kiril Raikoff,Michael J. Avram,Seema Singhal,Varsha Gandhi,Paul T. Schumacker,Nancy L. Krett,Steven T. Rosen +9 more
TL;DR: The potential of metabolic targeting as a broader means to kill and sensitize myeloma is established and a compound that can achieve this goal is identified.
Journal ArticleDOI
Functional proteomics outlines the complexity of breast cancer molecular subtypes
Angelo Gámez-Pozo,Lucía Trilla-Fuertes,Julia Berges-Soria,Nathalie Selevsek,Rocío López-Vacas,Mariana Díaz-Almirón,Paolo Nanni,Jorge M. Arevalillo,Hilario Navarro,Jonas Grossmann,Francisco Moreno,Rubén Gómez Rioja,Guillermo Prado-Vázquez,Andrea Zapater-Moros,Paloma Main,Jaime Feliu,Purificación Martínez del Prado,Pilar Zamora,Eva Ciruelos,Enrique Espinosa,Juan Ángel Fresno Vara +20 more
TL;DR: Protein expression-based probabilistic graphical model-based classification had prognostic value in patients with luminal A breast cancer and was independent of that provided by standard genomic tests for breast cancer, such as MammaPrint, OncoType Dx and the 8-gene Score.
Journal ArticleDOI
Metabolic adaptation in hypoxia and cancer.
TL;DR: In this article, the authors highlight the role of 2-oxoglutarate-dependent dioxygenases in HIF1α retrograde signaling during pseudohypoxia and discuss how these changes affect both the development of cancers and their resistance to treatment.
References
More filters
Journal ArticleDOI
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
TL;DR: Observations suggest that glutamine provides energy by aerobic oxidation from citric acid cycle metabolism, provides more than half of the cell energy when high concentrations of glucose are present, and greater than 98% when fructose or galactose is the carbohydrate.
Journal ArticleDOI
ATP citrate lyase inhibition can suppress tumor cell growth
Georgia Hatzivassiliou,Fangping Zhao,Daniel E. Bauer,Charalambos Andreadis,Shaw Antony N,Dashyant Dhanak,Sunil R. Hingorani,David A. Tuveson,Craig B. Thompson +8 more
TL;DR: ACL inhibition by RNAi or the chemical inhibitor SB-204990 limits in vitro proliferation and survival of tumor cells displaying aerobic glycolysis, and these treatments also reduce in vivo tumor growth and induce differentiation.